Nemonapride

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Nemonapride
Nemonapride.svg
Systematic (IUPAC) name
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
Clinical data
Trade names Emilace (JP)
AHFS/Drugs.com International Drug Names
Legal status
  • Rx-only (JP)
Routes of
administration
Oral
Identifiers
CAS Number 75272-39-8
ATC code none
PubChem CID: 4452
IUPHAR/BPS 983
UNII Q88T5P3444 YesY
KEGG D01468 YesY
Chemical data
Formula C21H26ClN3O2
Molecular mass 387.90 g/mol
  • CC1C(CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl
  (verify)

Nemonapride (エミレース, Emilace (JP)) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.

See also

References

Lua error in package.lua at line 80: module 'strict' not found.


<templatestyles src="Asbox/styles.css"></templatestyles>